Detalles de la búsqueda
1.
Real-world treatment outcomes of patients with penile cancer in the Kyushu-Okinawa area of Japan in the pre-guideline era.
Jpn J Clin Oncol
; 53(9): 837-844, 2023 Aug 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-37282601
2.
Final efficacy and safety results and biomarker analysis of a phase 2 study of cabozantinib in Japanese patients with advanced renal cell carcinoma.
Int J Clin Oncol
; 28(3): 416-426, 2023 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-36595123
3.
Prognostic value of programmed death-ligand 1 status in Japanese patients with renal cell carcinoma.
Int J Clin Oncol
; 26(11): 2073-2084, 2021 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-34291367
4.
Genome-wide association study of genetic variations associated with treatment failure after intravesical bacillus Calmette-Guérin therapy for non-muscle invasive bladder cancer.
Cancer Immunol Immunother
; 69(7): 1155-1163, 2020 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-32123936
5.
Surgical Navigation Improves Renal Parenchyma Volume Preservation in Robot-Assisted Partial Nephrectomy: A Propensity Score Matched Comparative Analysis.
J Urol
; 204(1): 149-156, 2020 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-31859597
6.
Difficulty in differential diagnosis for renal cancer with microscopic papillary architecture: overlapped pathological features among papillary renal cell carcinoma (RCC), mutinous tubular and spindle cell carcinoma, and unclassified RCC. Lessons from a Japanese multicenter study.
Jpn J Clin Oncol
; 50(11): 1313-1320, 2020 Oct 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-33089867
7.
A multicenter retrospective study of nivolumab monotherapy in previously treated metastatic renal cell carcinoma patients: interim analysis of Japanese real-world data.
Int J Clin Oncol
; 25(8): 1533-1542, 2020 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-32519026
8.
Cabozantinib in advanced renal cell carcinoma: A phase II, open-label, single-arm study of Japanese patients.
Int J Urol
; 27(11): 952-959, 2020 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-32789967
9.
Clinical significance of programmed death-1 and programmed death-ligand 1 expression in the tumor microenvironment of clear cell renal cell carcinoma.
Cancer Sci
; 110(6): 1820-1828, 2019 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-30972888
10.
Cigarette smoking augments androgen receptor activity and promotes resistance to antiandrogen therapy.
Prostate
; 79(10): 1147-1155, 2019 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-31077419
11.
Psoas muscle volume is correlated with sexual activity and erectile dysfunction among patients with localised prostate cancer.
Andrologia
; 51(9): e13354, 2019 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-31230398
12.
Treatment patterns and outcomes in patients with unresectable or metastatic renal cell carcinoma in Japan.
Int J Urol
; 26(2): 202-210, 2019 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-30345560
13.
Collateral resistance to taxanes in enzalutamide-resistant prostate cancer through aberrant androgen receptor and its variants.
Cancer Sci
; 109(10): 3224-3234, 2018 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-30051622
14.
Mineralocorticoid receptor signaling affects therapeutic effect of enzalutamide.
Prostate
; 2018 May 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-29851126
15.
Evaluation of efficacy and safety of sorafenib in kidney cancer patients aged 75 years and older: a propensity score-matched analysis.
Br J Cancer
; 119(2): 241-247, 2018 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-29891937
16.
The Association of Polymorphisms in the Gene Encoding Gonadotropin-Releasing Hormone with Serum Testosterone Level during Androgen Deprivation Therapy and Prognosis of Metastatic Prostate Cancer.
J Urol
; 199(3): 734-740, 2018 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-28941922
17.
Serum testosterone before and during androgen-deprivation therapy, and prognosis between cigarette smokers and nonsmokers with metastatic prostate cancer.
Andrologia
; 50(10): e13119, 2018 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-30084497
18.
Predictive factors of biochemical recurrence after radical prostatectomy for high-risk prostate cancer.
Int J Urol
; 25(3): 284-289, 2018 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-29315854
19.
Suppressed Recurrent Bladder Cancer after Androgen Suppression with Androgen Deprivation Therapy or 5α-Reductase Inhibitor.
J Urol
; 197(2): 308-313, 2017 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-27506696
20.
The Differential Impact of Body Mass Index and the Feature of Metabolic Syndrome on Oncological Outcomes Following Different Surgical Procedures in Japanese Men with Prostate Cancer.
Ann Surg Oncol
; 24(5): 1443-1450, 2017 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-27896516